Cerebrospinal fluid proteome profiling across the Alzheimer’s disease continuum: a step towards solving the equation for ‘X’
Sophia Weiner(Institute of Neurobiology), Johan Gobom(Sahlgrenska University Hospital), Fernando González‐Ortiz(Sahlgrenska University Hospital), Tuomas Rauramaa(University of Eastern Finland), Ville Leinonen(University of Eastern Finland), Nesrine Rahmouni(McGill University), Mathias Sauer(Sahlgrenska University Hospital), Stijn Servaes(Douglas Mental Health University Institute), Laia Montoliu‐Gaya(Sahlgrenska University Hospital), Cécile Tissot(Hirslanden Clinique des Grangettes), Henrik Zetterberg(University of Wisconsin–Madison), Pedro Rosa‐Neto(Center for Diagnosis and Research on Alzheimer's Disease), Nicholas J. Ashton(King's College London), Mikko Hiltunen(University of Eastern Finland), Andréa L. Benedet(University of Gothenburg), Jenna Stevenson(McGill University), Joseph Therriault(Douglas Mental Health University Institute), Kaj Blennow(Sahlgrenska University Hospital), Joel Simrén(University of Gothenburg)
Cited by 4
Related Papers
Defeating Alzheimer's disease and other dementias: a priority for European science and society
|The Lancet Neurology|2016|1.7k
Mapping neurotransmitter systems to the structural and functional organization of the human neocortex
|Nature Neuroscience|2022|773
Differences Between Plasma and Cerebrospinal Fluid Glial Fibrillary Acidic Protein Levels Across the Alzheimer Disease Continuum
|JAMA Neurology|2021|627
Resistance to autosomal dominant Alzheimer’s disease in an APOE3 Christchurch homozygote: a case report
|Nature Medicine|2019|606
The Alzheimer's Association appropriate use recommendations for blood biomarkers in Alzheimer's disease
|Alzheimer s & Dementia|2022|589